Currently, our screening includes 23 biopharma stocks that have risen by at least 10% in the last 20 days. However, not every price increase is synonymous with long-term return potential. In many cases, the short-term growth is purely speculative, as the companies in question have not yet generated any revenue, and it is unclear when this will change....
The Best Growth Stocks by Revenue Growth
Stocks with high revenue growth on a TTM basis, sorted by distance to the 52-week high.
| Rank | Stock | Price | Rev. Gr. | Dist. 52WH | Perf. 20D |
|---|---|---|---|---|---|
| WKN | Symbol | EPS Growth | Rel. Strength | |||
| 1 | Palomar Holdings | 130.13 $ | 40.22 % | 9.49 % | -0.24 % |
| A2PHB6 | PLMR | 49.48 % | 96 | |||
| 2 | HCI Group | 137.20 $ | 49.16 % | 9.67 % | -1.52 % |
| A1W02H | HCI | 199.39 % | 85 | |||
| 3 | Alignment Healthcare | 18.84 $ | 48.25 % | 10.54 % | 19.92 % |
| A2QSBM | ALHC | - % | 99 | |||
| 4 | HEICO | 187.93 $ | 43.13 % | 14.27 % | -5.63 % |
| 914043 | HEI/A | 19.31 % | 87 | |||
| 5 | Heico | 238.62 $ | 43.13 % | 15.86 % | -5.58 % |
| 889997 | HEI | 19.31 % | 88 | |||
| 6 | StoneX Group | 70.30 $ | 64.14 % | 17.76 % | -3.65 % |
| A2P8CE | SNEX | 7.01 % | 95 | |||
| 7 | Catalyst Pharmaceuticals | 20.86 $ | 32.17 % | 20.27 % | -1.62 % |
| A0LCUL | CPRX | 111.86 % | 90 | |||
| 8 | Newmont | 46.64 $ | 53.66 % | 20.57 % | 6.90 % |
| 853823 | NEM | - % | 83 | |||
| 9 | Rhythm Pharmaceuticals | 53.57 $ | 81.55 % | 21.89 % | 4.38 % |
| A2H5A0 | RYTM | - % | 87 | |||
| 10 | Mercadolibre | 1,842.40 $ | 43.63 % | 22.44 % | -8.13 % |
| A0MYNP | MELI | 43.98 % | 86 | |||
Subscribe now to see the full ranking
Already a subscriber? Login
Sample Issue
$
0
one issue
Bestseller
Trial Subscription
$
33
1 month